跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rozuvas 20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rozuvas 20
Approved
STANDARD
Rozuvas 20
Magbro Healthcare Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d93950f61acd708a
Company
Magbro Healthcare Pvt. Ltd
Type
Standard
Approval Details
Approval Id
d93950f61acd708a
Drug Approval Philippines Name
Rozuvas 20
Product Name
Rozuvas 20
Registration Number
DRP-9986-02
Brand Name
Rozuvas 20
Generic Name
Rosuvastatin (as calcium)
Dosage Form
Tablet
Dosage Strength
20 mg
Manufacturer
Magbro Healthcare Pvt. Ltd
Importer
Teramedix Pharma Trading Inc.
Distributor
RoDaise Pharma Distributor Corporation
Issuance Date
24 January 2025
Expiry Date
08 July 2025
Pharmacologic Category
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d93950f61acd708a
Type
Standard
Back to Philippines FDA Approvals